North Carolina Medicaid plans to end GLP-1 coverage for weight loss on Oct
The RACGP has been calling for effective obesity-management medication to be subsidised on the Pharmaceutical Benefits Scheme (PBS) to reduce health inequity and remove the cost barrier for many Australians
Should clinicians expect increased patient demand
Clin Cancer Res 14(24):8295-8301, 2008
Retatrutide 20mg Pen is not intended for human consumption, veterinary use, self-administration, clinical use, treatment, diagnosis, prevention, cosmetic use, supplement use, body composition use, wellness use, weight-loss use or any form of personal use
At 411, seeing 150 pounds on the scale during my physical was a wake-up call